Stryker's Inari Medical Launches Innovative InThrill Thrombectomy System for Vascular Care Advancement
- Inari Medical, now part of Stryker, launched the InThrill Thrombectomy System for small vessel thrombectomy.
- The InThrill system features enhanced design for efficient clot removal, improving patient outcomes.
- Inari Medical's integration into Stryker strengthens its position in the vascular care market.
Inari Medical Unveils Groundbreaking InThrill Thrombectomy System to Revolutionize Vascular Care
Inari Medical, now part of Stryker, recently announces the launch of its next-generation InThrill Thrombectomy System, a notable advancement in the realm of medical technology specifically designed for small vessel and arteriovenous (AV) access thrombectomy. This innovative system distinguishes itself as the first of its kind tailored for these applications, facilitating the rapid and complete removal of clots from blood vessels. At its core, the InThrill Thrombectomy System features an 8 French over-the-wire design, which includes a thrombectomy catheter and sheath optimized for enhanced efficiency in clot removal.
The InThrill system boasts several key features that set it apart from existing solutions. It incorporates increased radial force for improved wall apposition, allowing for more effective engagement with clots. Additionally, the device has an offset single open mouth that enhances clot capture, ensuring a thorough removal process. Internal struts are designed to promote even distribution of clot material, while the redesigned backend significantly improves user ergonomics, making it easier for medical professionals to operate. These innovations reflect Inari Medical's commitment to delivering solutions that address real-world challenges in vascular care.
The first commercial application of the InThrill Thrombectomy System takes place on May 19, 2025, conducted by Dr. Joshua Pinter and Dr. Anish Ghodadra at the UPMC health care system. The two physicians commend the system for its effectiveness and consistency during thrombectomies, highlighting its potential to enhance patient outcomes. Tim Lanier, president of the Inari Division, underscores the company's dedication to collaborating with vascular physicians and enhancing healthcare delivery through this cutting-edge technology. The launch of the InThrill Thrombectomy System represents a significant leap in treating AV access thrombectomy, showcasing Inari Medical's ongoing commitment to innovation in the healthcare sector.
In addition to the launch of the InThrill system, Inari Medical's integration into Stryker signifies a strategic move to bolster the company’s position in the vascular care market. This partnership allows for the sharing of technological advancements and best practices, further expanding the range of solutions available to healthcare providers. As the demand for effective thrombectomy solutions increases, the introduction of the InThrill system positions Inari Medical as a leader in addressing the growing needs of patients with vascular conditions.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

